BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2508850)

  • 1. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
    Brook MG; Chan G; Yap I; Karayiannis P; Lever AM; Jacyna M; Main J; Thomas HC
    BMJ; 1989 Sep; 299(6700):652-6. PubMed ID: 2508850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy.
    Saracco G; Mazzella G; Rosina F; Cancellieri C; Lattore V; Raise E; Rocca G; Giorda L; Verme G; Gasbarrini G
    Hepatology; 1989 Sep; 10(3):336-41. PubMed ID: 2668148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection.
    Brook MG; Main J; Yap I; Chan G; Karayiannis P; Crossey M; Thomas HC
    Aliment Pharmacol Ther; 1993 Jun; 7(3):331-6. PubMed ID: 8364139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
    J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.
    Jacyna MR; Brooks MG; Loke RH; Main J; Murray-Lyon IM; Thomas HC
    BMJ; 1989 Jan; 298(6666):80-2. PubMed ID: 2493302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy.
    Caselmann WH; Eisenburg J; Hofschneider PH; Koshy R
    Gastroenterology; 1989 Feb; 96(2 Pt 1):449-55. PubMed ID: 2492011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
    Ruiz-Moreno M; Rúa MJ; Moraleda G; Guardia L; Moreno A; Carreño V
    Pediatrics; 1992 Aug; 90(2 Pt 1):254-8. PubMed ID: 1641292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
    McDonald JA; Caruso L; Karayiannis P; Scully LJ; Harris JR; Forster GE; Thomas HC
    Hepatology; 1987; 7(4):719-23. PubMed ID: 3038722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
    Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
    Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.
    Mellerup MT; Krogsgaard K; Mathurin P; Gluud C; Poynard T
    Cochrane Database Syst Rev; 2002; (2):CD000345. PubMed ID: 12076393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
    Brook MG; Karayiannis P; Thomas HC
    Hepatology; 1989 Nov; 10(5):761-3. PubMed ID: 2680866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B.
    Ruiz-Moreno M; Rua MJ; Molina J; Moraleda G; Moreno A; García-Aguado J; Carreño V
    Hepatology; 1991 Jun; 13(6):1035-9. PubMed ID: 2050319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
    Alexander GJ; Fagan EA; Guarner P; Rolando N; Brahm J; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S183-8. PubMed ID: 3298406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa.
    Lok AS; Chung HT; Liu VW; Ma OC
    Gastroenterology; 1993 Dec; 105(6):1833-8. PubMed ID: 8253359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.